Business Description
Bio Medica Laboratories Ltd
ISIN : INE1BKA01015
Compare
Compare
Traded in other countries / regions
BMLL.India IPO Date
2026-05-29Description
Bio Medica Laboratories Ltd is engaged in the manufacturing of Pharmaceutical Parenteral Formulations. It manufactures generic drugs in the form of injectables namely Liquid Injections and Dry Powder Injections. These injectables are available in both single dose and multi dose forms, catering both human and veterinary needs. Its products address a wide range of medical needs and preferences. The majority of revenue is derived from the sales of Liquid injections. Geographically, it operates predominantly in India, and internationally, it exports to Afghanistan.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Equity-to-Asset | 0.38 | |||||
Debt-to-Equity | 1.02 | |||||
Debt-to-EBITDA | 0.97 | |||||
Interest Coverage | 10.82 | |||||
Piotroski F-Score | N/A/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 73.26 | |||||
9-Day RSI | 69.55 | |||||
14-Day RSI | 67.42 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.83 | |||||
Quick Ratio | 0.76 | |||||
Days Inventory | 229.66 | |||||
Days Sales Outstanding | 30.75 | |||||
Days Payable | 56.75 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 46.94 | |||||
Operating Margin % | 37.62 | |||||
Net Margin % | 25.64 | |||||
EBITDA Margin % | 40.52 | |||||
FCF Margin % | -9.66 | |||||
OCF Margin % | -9.61 | |||||
ROE % | 99.59 | |||||
ROA % | 33.4 | |||||
ROIC % | 41.99 | |||||
ROC (Joel Greenblatt) % | 63.98 | |||||
ROCE % | 82.45 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 18.5 | |||||
PE Ratio without NRI | 18.5 | |||||
PS Ratio | 4.74 | |||||
PB Ratio | 12.3 | |||||
Price-to-Tangible-Book | 12.3 | |||||
EV-to-EBIT | 15.15 | |||||
EV-to-EBITDA | 14.17 | |||||
EV-to-Revenue | 5.74 | |||||
EV-to-FCF | -59.4 | |||||
Price-to-Graham-Number | 3.18 | |||||
| Price-to-Net-Current-Asset-Value | 27.04 | |||||
Earnings Yield (Greenblatt) % | 6.6 | |||||
FCF Yield % | -2.04 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bio Medica Laboratories Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 381.952 | ||
| EPS (TTM) (₹) | 7.789 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 67.42 | ||
| 14-Day ATR (₹) | 7.415294 | ||
| 20-Day SMA (₹) | 128.0875 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (₹) | 101.5 - 148 | ||
| Shares Outstanding (Mil) | 12.58 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bio Medica Laboratories Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bio Medica Laboratories Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Bio Medica Laboratories Ltd Frequently Asked Questions
What is Bio Medica Laboratories Ltd(NSE:BMLL)'s stock price today?
The current price of NSE:BMLL is ₹144.10. The 52 week high of NSE:BMLL is ₹148.00 and 52 week low is ₹101.50.
When is next earnings date of Bio Medica Laboratories Ltd(NSE:BMLL)?
The next earnings date of Bio Medica Laboratories Ltd(NSE:BMLL) is .
Does Bio Medica Laboratories Ltd(NSE:BMLL) pay dividends? If so, how much?
Bio Medica Laboratories Ltd(NSE:BMLL) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Bio Medica Laboratories Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers